Document Detail

Lymphocytes are not only immunocytes.
MedLine Citation:
PMID:  7370376     Owner:  NLM     Status:  MEDLINE    
Only one of the many functions of lymphocytes is their participation in host immune responses. Lymphoid cells also probably participate in a number of physiological processes aimed at maintenance of homeostasis. It was first suggested half a century ago that lymphocytes may function as trephocytes and regulate the growth of various organs. Evidence is presented in support of this hypothesis.
I J Fidler
Related Documents :
6972906 - Evidence for the presence of a low molecular-weight activator of suppressor monocytes (...
25385796 - What is a host? incorporating the microbiota into the 'damage-response framework'
6984346 - Colostral t lymphocytes detected by intracytoplasmic and membrane markers.
20460176 - Chemopreventive anti-cancer agent acyclic retinoid suppresses allogeneic immune respons...
22287606 - Emerging evidence for endoplasmic reticulum stress in the pathogenesis of idiopathic pu...
19664706 - Involvement of pi3k-akt-bad pathway in apoptosis induced by 2,6-di-o-methyl-beta-cyclod...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Biomedicine / [publiée pour l'A.A.I.C.I.G.]     Volume:  32     ISSN:  0300-0893     ISO Abbreviation:  Biomedicine     Publication Date:  1980 Feb 
Date Detail:
Created Date:  1980-07-12     Completed Date:  1980-07-12     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0361342     Medline TA:  Biomedicine     Country:  FRANCE    
Other Details:
Languages:  eng     Pagination:  1-3     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cell Division
Growth Substances / biosynthesis
Hyperplasia / physiopathology
Lymphocytes / immunology,  physiology*
Neoplasms / physiopathology
Reg. No./Substance:
0/Growth Substances

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A treatment allocation procedure for sequential clinical trials.
Next Document:  Study of 131I-rose bengal kinetics in normal man: a critical evaluation of a three-compartment model...